Top 5 China Biomanufacturing Trends in 2024

China's biopharmaceutical market is experiencing significant growth, propelled by a combination of demographic trends, rapidly expanding health expenditures, and strategic Chinese government policies aimed at fostering innovation within the industry.

By 2024, this growth is expected to be particularly driven by the biologics sector, with a focus on antibodies. Currently, China's sales in this area lag behind global benchmarks, but they are poised for substantial expansion.

Over the years, the biopharmaceutical industry in China has transformed from a low-cost biomanufacturer into a formidable research and development powerhouse. This transformation has allowed China to establish a significantly larger presence in the global market.

In 2023, 5 notable trends are emerging in China's biologics manufacturing sector, and these trends are expected to exert a substantial influence on future developments.

Download the e-Book HERE

‍

‍